Tiziana Mele, managing director of Lundbeck Italia, explains the impact of COVID on mental health care from the perspective of a company dedicated to brain health, outlines the Italian operation that includes both commercial and production capacities and shares Lundbeck’s support of independent clinical trials in the country.
The pandemic has changed the priorities of the general population, but it has also challenged the agenda of health professionals, including psychiatrists and other healthcare professionals.
